호흡기내치료 디바이스 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Respiratory Endotherapy Devices Market size is expected to reach USD 3.42 Billion in 2034 from USD 2.07 Billion (2025) growing at a CAGR of 5.72% during 2026-2034.

The Global Respiratory Endotherapy Devices Market is witnessing substantial growth due to the increasing burden of chronic respiratory diseases. Conditions such as asthma, chronic obstructive pulmonary disease, and lung cancer are rising globally. Air pollution, smoking prevalence, and occupational hazards are key contributing factors. Minimally invasive bronchoscopic procedures are gaining preference due to shorter recovery times. Healthcare providers are increasingly adopting advanced respiratory devices to improve patient outcomes.

Technological innovation is transforming the market landscape significantly. Robotic-assisted bronchoscopy and enhanced imaging systems are improving diagnostic precision. New device designs are enabling more accurate tumor localization and biopsy procedures. Hospitals and specialty clinics are investing heavily in advanced endotherapy equipment. The growing elderly population, which is more susceptible to respiratory illnesses, is further driving demand.

Future growth will be supported by expanding healthcare infrastructure in developing regions. Increasing awareness about early detection of lung diseases will boost procedural volumes. Integration of artificial intelligence in diagnostic imaging will enhance procedural efficiency. Continuous product development aimed at reducing complications will strengthen adoption rates. The market outlook remains strong as respiratory health becomes a global healthcare priority.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Devices

• Diagnostic Devices
• Therapeutic Devices
• Peripheral Vascular Intervention
• Endovascular Interventions
• Cardiac
• Interventional Radiology
• Venous
• Others

By End User

• Hospitals
• Diagnostic Centers
• Ambulatory Surgical Centers

By Specialist

• Cardiologists
• Radiologists
• Vascular Surgeons
• Others

COMPANIES PROFILED

• Fujifilm Holdings Corporation, Medtronic plc, Johnson Johnson, Smith Nephew Plc, Stryker Corporation, Olympus Corporation, Hoya Corporation, Steris Healthcare, Conmed Corporation, Boston Scientific Corporation
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET: BY DEVICES 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Devices
• 4.2. Diagnostic Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Therapeutic Devices Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.4. Peripheral Vascular Intervention Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.5. Endovascular Interventions Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.6. Cardiac Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.7. Interventional Radiology Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.8. Venous Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.9. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET: BY END USER 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast End User
• 5.2. Hospitals Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Diagnostic Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Ambulatory Surgical Centers Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET: BY SPECIALIST 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast Specialist
• 6.2. Cardiologists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Radiologists Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Vascular Surgeons Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.5. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL RESPIRATORY ENDOTHERAPY DEVICES MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Devices
  • 7.2.2 By End User
  • 7.2.3 By Specialist
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Devices
  • 7.3.2 By End User
  • 7.3.3 By Specialist
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Devices
  • 7.4.2 By End User
  • 7.4.3 By Specialist
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Devices
  • 7.5.2 By End User
  • 7.5.3 By Specialist
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Devices
  • 7.6.2 By End User
  • 7.6.3 By Specialist
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL RESPIRATORY ENDOTHERAPY DEVICES INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Fujifilm Holdings Corporation
  • 9.2.2 Medtronic Plc
  • 9.2.3 Johnson & Johnson
  • 9.2.4 Smith & Nephew Plc
  • 9.2.5 Stryker Corporation
  • 9.2.6 Olympus Corporation
  • 9.2.7 Hoya Corporation
  • 9.2.8 Steris Healthcare
  • 9.2.9 Conmed Corporation
  • 9.2.10 Boston Scientific Corporation